dr. smith discusses brentuximab vedotin in ctcl
Published 6 years ago • 223 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:15
dr. ai on the efficacy of brentuximab vedotin in patients with advanced cutaneous t-cell lymphoma
-
0:41
dr. brammer on fda approval of brentuximab vedotin in ctcl
-
5:14
brentuximab vedotin in hodgkin lymphoma
-
2:46
alcanza: brentuximab vedotin for ctcl
-
0:44
dr. hamlin on brentuximab vedotin pharmacology
-
1:25
dr. brammer on brentuximab vedotin for patients with t-cell lymphoma
-
0:58
approval of brentuximab vedotin for cd30 mycosis fungoides
-
1:30
dr. william on brentuximab vedotin/lenalidomide in cutaneous/peripheral t-cell lymphomas
-
1:31
dr. moskowitz on the alcanza trial in ctcl
-
6:59
hodgkin lymphoma: upfront brentuximab vedotin avd
-
3:00
primary cutaneous t-cell lymphoma: alcanza trial
-
6:24
joseph connors, md: bleomycin or brentuximab vedotin in hodgkin lymphoma?
-
1:01
dr. ai on potential with mogamulizumab in ctcl
-
45:49
pathology grand rounds - cutaneous t-cell lymphoma | dr. michi shinohara
-
54:14
quality of life: the long-term impact of living with cutaneous lymphoma
-
4:55
how is diffuse large b-cell lymphoma (dlbcl) treated?
-
1:22
dr. cohen on the evolution of antibodies in lymphoma
-
0:39
diffuse large b-cell lymphoma | michael tees, m.d. | colorado blood cancer institute
-
2:10
answers from the experts: cutaneous b-cell lymphoma